Form 4 for IDYA IDEAYA Biosciences, Inc.
Accepted 2024-02-05 00:00:00 ET · period of report 2024-02-01 · accession 0001610717-24-000043 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-02-05 | 2024-02-01 | IDYA | Hata Yujiro S | Pres, CEO, Dir | M - OptEx | $4.31 | +628 | 678.5K | +0.1% | +$2,707 |
| DMT | 2024-02-05 | 2024-02-01 | IDYA | Hata Yujiro S | Pres, CEO, Dir | S - Sale+OE | $45.00 | -628 | 677.9K | -0.1% | -$28.3K |
| DT | 2024-02-05 | 2024-02-01 | IDYA | Hata Yujiro S | Pres, CEO, Dir | M - OptEx | $0.00 | -628 | 323.8K | -0.2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-01 | M | A | 628 | $4.31 | 678,515 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-01 | S | D | 4 | $45.01 | 677,887 | D | — | — | |
| 3 | Common | Common Stock | 2024-02-01 | S | D | 624 | $45.00 | 677,891 | D | — | — | |
| 4 | Derivative | Stock Option (right to buy) | 2024-02-01 | M | D | 628 | $0.00 | 323,826 | D | $4.31 · — to 2028-02-26 | 628 Common Stock | (F2) The shares subject to the option are fully vested and exercisable. |